News Main Page

Email A Friend

More News

May 25, 2023
California's DIR Division of Workers' Compensation Issues Notice of Public Hearing on June 26, 2023 for Proposed Evidence-Based Updates to the Medical Treatment Utilization Schedule

May 18, 2023
California Division of Workers' Compensation (DWC) Posts Additional Adjustments to Official Medical Fee Schedule (Hospital Outpatient Departments/Ambulatory Surgical Centers)

May 12, 2023
Calif Division of Workers' Compensation Issues Notice of 15-Day Public Comment Period for QME Process Regulations

May 3, 2023
California Division of Workers' Compensation Posts Adjustments to Official Medical Fee Schedule (Hospital Outpatient Departments/Ambulatory Surgical Centers)

The Division of Workers’ Compensation (DWC) invites California licensed physicians (medical doctors or doctors of osteopathy) and pharmacists to submit applications to serve on the workers’ compensation Pharmacy & Therapeutics Committee.

The role of the Pharmacy & Therapeutics Committee is to advise the DWC Administrative Director on updates and improvements to the Medical Treatment Utilization Schedule’s drug formulary. The members of the committee are appointed by the Administrative Director pursuant to Labor Code section 5307.29. The committee meets quarterly (January, April, July, and October) and members serve a two-year term. The terms of six members are expiring soon.

Applications are currently being accepted to fill six positions on the committee, three physician positions and three pharmacist positions. Current members are eligible to reapply to serve on the committee for another two-year term. The application form, conflict of interest disclosure form, and regulations setting forth committee member qualifications and duties are posted online. Committee members serve as volunteers without compensation, and are reimbursed for some travel expenses.

DWC requests that completed application packages be submitted to formulary@dir.ca.gov by the close of business on Friday, May 12, 2023. Questions about the application process can be emailed to formulary@dir.ca.gov with the subject line “P&T Application Question.”

# # #